MEDRAD Recognized by Frost & Sullivan for Customer Value Enhancement in Multiparameter Monitoring.

PALO ALTO, Calif. -- Frost & Sullivan recently presented MEDRAD, INC. with the 2005 Multiparameter Monitoring Customer Value Enhancement Award in recognition of the company's new, high-value product, the Veris(TM) MR Vital Signs Monitor.

By continuing to develop novel solutions to suit the customers' needs, MEDRAD has enhanced the value proposition of its products and achieved a product that meets the needs of customers in this challenging market segment.

In response to demand for greater patient safety, the company developed the Veris MR Vital Signs Monitor, which is compatible with 3 tesla (T) magnetic fields. Further, it also developed pulse oximeter and electrocardiograph (ECG) technologies with fiber optics to provide reliable, robust performance free of magnetic interference during magnetic resonance imaging (MRI) monitoring.

The need for vital signs monitoring during MRI procedures has increased with the predominance of imaging during acute diagnostics and the advantages of MRI over other imaging modalities, especially for children and infants. Since imaging equipment has been designed to fit primarily adults, MEDRAD designed accessories for the Veris monitor to accommodate almost any patient age and size, with specific attention to pediatric and neonate patients.

The company also extended the device's battery-life to accommodate prolonged patient imaging procedures and transport. An integral tray was designed to efficiently hold extra cables, store accessories, and extend the working space. All features were specifically aimed to facilitate studies in MRI.

"As the monitor's main use may be limited to MRI or imaging facilities, the device has been built with a user-friendly interface that facilitates fast and efficient operation for even infrequent uses," says Frost & Sullivan research analyst Nathan Cohen. "With up to six simultaneous waveform displays, it can be used to easily compare 5-lead ECG and display other key vitals such as pulse oximetry and capnography."

Standard monitoring equipment must remain outside the magnetically charged scan room or risk being magnetically attracted into the bore of the system. The Veris monitor reduces the risk through special materials and shielding that prevent it from being magnetically attracted. Control of the monitor is available at the patient's side or with a remote monitoring display control unit that can be easily set up in a control room or another central location.

Another value-enhancing feature of the Veris monitor is its range of configurations that specifically satisfy the particular needs of end-users in a variety of specialties. MEDRAD integrated six configurations into its monitor to meet the needs of healthcare professionals in anesthesia, sedation, cardiac MR, research, and basic patient monitoring.

This multiple configuration feature is a powerful tool for increasing the applications of the device. By providing a flexible display with an intuitive interface, MEDRAD has greatly enhanced the value of its product.

"Moreover, shortened acute-care stays for patients are raising the need for continuous vital signs monitoring to ensure patient safety," observes Cohen. "The Veris monitor's versatility, reliability, and ease-of-use will greatly improve patient monitoring efforts in imaging facilities and offer tremendous value for end-users."

Frost & Sullivan presents its Customer Value Enhancement Award to the company that has demonstrated the ability to expand its customer base, while maintaining its existing installed base, with more innovative value creation and enhancement strategies than competitors. The Award lauds successful sales entry, customer acquisition and service strategies, and the degree to which those strategies have met customers' stated requirements.

MEDRAD received the Award at Frost & Sullivan's third annual Customer Value Enhancement Awards banquet in Boston, Massachusetts, on July 20.

About MEDRAD, INC.

MEDRAD, INC. is a worldwide leading provider of medical devices and services that enable and enhance imaging procedures of the human body. Used in diagnostic imaging, MEDRAD's product offerings include a comprehensive line of vascular injection systems, magnetic resonance (MR) surface coils and accessory products, and equipment services. Total 2004 revenues were $344 million. MEDRAD is a 2003 recipient of the Malcolm Baldrige National Quality Award, the top honor a U.S. company can receive for quality and business excellence. The company's world headquarters is near Pittsburgh, Pennsylvania, in the United States. MEDRAD is a U.S. affiliate of Schering AG, Germany (NYSE:SHR). For more information, visit MEDRAD's website at www.medrad.com.

About Frost & Sullivan

Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit http://www.frost.com.